强化胰岛素治疗在冠状动脉旁路移植术中的应用进展  

The Application Progress of Intensive Insulin Therapy in Patients after Coronary Artery Bypass Graft

作　　者：余义文[1] 王亮[2] 

机构地区：[1]内蒙古医科大学,呼和浩特010000 [2]包头市中心医院心外科,内蒙古包头014000

出　　处：《医学综述》2014年第11期2007-2009,共3页Medical Recapitulate

摘　　要：冠状动脉旁路移植术(CABG)后高血糖现象普遍存在。持续的高血糖对CABG患者近期及远期预后会产生不良影响。强化胰岛素治疗能够改善其临床预后,但是过分控制血糖容易导致低血糖的发生。最佳的血糖控制方案既能较好地控制血糖,又不造成低血糖的发生,从而降低CABG患者术后的并发症发生率及病死率,改善临床预后。但是,目前强化胰岛素治疗在血糖控制目标上还有很多争议。Hyperglycemia is common after coronary artery bypass graft（ CABG）. Continuous high level of blood glucose has a negative on the influence of the short-term and long-term prognosis of patients with CABG. Intensive insulin therapy can improve outcomes, but it may cause hypoglycemia under tight glycemic control. Optimal glycemic control can make good blood glucose control without causing hypoglycemia, thus reducing postoperative complications and mortality, improving clinical outcomes in patients undergoing CABG. There are still a lot of debates about the blood sugar control target by intensive insulin therapy at present.

关 键 词：冠状动脉旁路移植术 高血糖 强化胰岛素治疗 

分 类 号：R654.1[医药卫生—外科学] R654.2[医药卫生—临床医学]